TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $291,764 | -77.1% | 34,900 | -31.8% | 0.00% | -75.0% |
| Q2 2023 | $1,271,808 | +5.3% | 51,200 | -36.2% | 0.01% | 0.0% |
| Q1 2023 | $1,207,712 | +74.8% | 80,300 | +37.5% | 0.01% | +71.4% |
| Q4 2022 | $690,872 | +119.4% | 58,400 | +9.8% | 0.01% | +75.0% |
| Q3 2022 | $314,944 | +121.8% | 53,200 | +257.0% | 0.00% | +300.0% |
| Q1 2022 | $142,000 | -57.7% | 14,900 | -15.8% | 0.00% | -50.0% |
| Q4 2021 | $336,000 | -25.0% | 17,700 | +90.3% | 0.00% | -50.0% |
| Q1 2021 | $448,000 | -32.7% | 9,300 | -27.3% | 0.00% | -42.9% |
| Q4 2020 | $666,000 | -13.3% | 12,800 | -55.4% | 0.01% | -22.2% |
| Q3 2020 | $768,000 | -50.2% | 28,700 | -63.8% | 0.01% | -50.0% |
| Q2 2020 | $1,543,000 | +35.0% | 79,200 | -31.8% | 0.02% | +12.5% |
| Q1 2020 | $1,143,000 | +14.0% | 116,200 | +28.5% | 0.02% | +45.5% |
| Q4 2019 | $1,003,000 | +377.6% | 90,400 | +141.7% | 0.01% | +450.0% |
| Q3 2019 | $210,000 | – | 37,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |